Quintiles Transnational Corp.

Pharmaceutical services company reports 3rd quarter net revenue of $470.3 million

Published in Lab Law Weekly, December 16th, 2005

Quintiles Transnational Corp. announced financial results for the quarter ended September 30, 2005 with net revenue of $470.3 million, an increase of 19% from net revenue of $396.5 million for third quarter 2004. Profit contribution from Quintiles' product development and commercial services groups totaled $210.5 million in third quarter 2005, up from $193.1 million for third quarter 2004.

Net income for third quarter 2005 was $26.9 million, after $3.4 million in charges relating to the company's previously announced restructuring program, compared to a net income of $34.5 million in third quarter 2004. Quintiles' effective income tax rate for the third quarter of 2005...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2005-12-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry